171
Views
1
CrossRef citations to date
0
Altmetric
Articles

Empirical Bayes estimators in hierarchical models with mixture priors

Pages 2958-2980 | Received 29 Jun 2017, Accepted 02 Mar 2018, Published online: 15 Mar 2018

References

  • E.O. Bayman, K. Chaloner, and M.K. Cowles, Detecting qualitative interaction: A Bayesian approach, Stat. Med. 29 (2010), pp. 455–463.
  • J.O. Berger, X. Wang, and L. Shen, A Bayesian approach to subgroup identification, J. Biopharm. Stat. 24 (2014), pp. 110–129. doi: 10.1080/10543406.2013.856026
  • J.G. Booth and J.P. Hobert, Standard errors of prediction in generalized linear mixed models, J. Amer. Statist. Assoc. 93 (1998), pp. 262–272. doi: 10.1080/01621459.1998.10474107
  • B.P. Carlin and T.A. Louis, Empirical Bayes: Past, present and future, J. Amer. Statist. Assoc. 95 (2000), pp. 1286–1289. doi: 10.1080/01621459.2000.10474331
  • B.P. Carlin and T.A. Louis, Bayesian Methods for Data Analysis, 3rd ed., Chapman and Hall/CRC, Boca Raton, 2009.
  • G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller, Efficacy of bcg vaccine in the prevention of tuberculosis, J. Am. Med. Assoc. 271 (1994), pp. 698–702. doi: 10.1001/jama.1994.03510330076038
  • S. Dalal and W. Hall, Approximating priors by mixtures of natural conjugate priors, J. R. Stat. Soc. Ser. B 45 (1983), pp. 278–286.
  • C.E. Davis and D.P. Leffingwell, Empirical Bayes estimates of subgroup effects in clinical trials, Control. Clin. Trials 11 (1990), pp. 37–42. doi: 10.1016/0197-2456(90)90030-6
  • A.P. Dempster, N.M. Laird, and D.B. Rubin, Maximum likelihood from incomplete data via the EM algorithm (with discussion), J. R. Stat. Soc. B 39 (1977), pp. 1–38.
  • R. DerSimonian and N. Laird, Meta-analysis in clinical trials, Control. Clin. Trials 7 (1986), pp. 177–188. doi: 10.1016/0197-2456(86)90046-2
  • W. DuMouchel, Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system, Am. Stat. 53 (1999), pp. 177–190.
  • B. Efron, Size, power and false discovery rates, Ann. Statist. 35 (2007), pp. 1351–1377. doi: 10.1214/009053606000001460
  • B. Efron, Tweedie's formula and selection bias, J. Amer. Statist. Assoc. 106 (2011), pp. 1602–1614. doi: 10.1198/jasa.2011.tm11181
  • B. Efron and C. Morris, Stein's estimation rule and its competitors – an empirical Bayes approach, J. Amer. Statist. Assoc. 68 (1973), pp. 117–130.
  • B. Efron and C. Morris, Data analysis using Stein's estimator and its generalizations, J. Amer. Statist. Assoc. 70 (1975), pp. 311–319. doi: 10.1080/01621459.1975.10479864
  • S. Greenland, Principles of multilevel modelling, Int. J. Epidemiol. 29 (2000), pp. 158–167. doi: 10.1093/ije/29.1.158
  • J.M. Grouin, M. Coste, and J. Lewis, Subgroup analyses in randomized clinical trials: Statistical and regulatory issues, J. Biopharm. Stat. 15 (2005), pp. 869–882. doi: 10.1081/BIP-200067988
  • W. James and C. Stein, Estimation with quadratic loss, Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, 1961, pp. 361–379.
  • H.E. Jones, D.I. Ohlssen, B. Neuenschwander, A. Racine, and M. Branson, Bayesian models for subgroup analysis in clinical trials, Clin. Trials 8 (2011), pp. 129–143. doi: 10.1177/1740774510396933
  • R.E. Kass and D. Steffey, Approximate Bayesian inference in conditionally independent hierarchical models (parametric empirical Bayes models), J. Amer. Statist. Assoc. 84 (1989), pp. 717–726. doi: 10.1080/01621459.1989.10478825
  • C.N. Morris, Parametric empirical Bayes inference: Theory and applications, J. Amer. Statist. Assoc. 78 (1983), pp. 47–55. doi: 10.1080/01621459.1983.10477920
  • B. Neuenschwander, S. Wandel, S. Roychoudhury, and S. Bailey, Robust exchangeability designs for early phase clinical trials with multiple strata, Pharm. Stat. 15 (2015), pp. 123–134. doi: 10.1002/pst.1730
  • J.S. Remington, B. Efron, E. Cavanaugh, H. Simon, and A. Trejos, Studies on toxoplasmosis in El Savador prevalence and incidence of toxoplasmosis as measured by the Sabin-Feldman dye test, Trans. R. Soc. Trop. Med. Hyg. 64 (1970), pp. 252–267. doi: 10.1016/0035-9203(70)90132-X
  • H. Robbins, An empirical Bayes approach to statistics, Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability, 1956, pp. 157–163.
  • G.K. Rosenkranz, An approach to integrated safety analyses of clinical studies, Drug. Inf. J. 44 (2010), pp. 649–657. doi: 10.1177/009286151004400601
  • G.K. Rosenkranz, Bootstrap corrections of treatment effect estimates following selection, Comput. Statist. Data Anal. 69 (2014), pp. 220–227. doi: 10.1016/j.csda.2013.08.010
  • H. Schmidli, S. Gsteiger, S. Roychoudhury, A. O'Hagan, D. Spiegelhalter, and B. Neuenschwander, Robust meta-analytic-predictive priors in clinical trials with historical control information, Biometrics 70 (2014), pp. 1023–1032. doi: 10.1111/biom.12242
  • D.A. Schoenfeld, Sample-size formula for the proportional-hazards regression model, Biometrics 39 (1983), pp. 499–503. doi: 10.2307/2531021
  • M.C. Simmonds and J.P.T. Higgins, A general framework for the use of logistic regression models in meta-analysis, Stat. Methods Med. Res. 25 (2016), pp. 2858–2877. doi: 10.1177/0962280214534409
  • D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers, Gene expression correlates of clinical prostate cancer behavior, Cancer Cell 1 (2002), pp. 203–209. doi: 10.1016/S1535-6108(02)00030-2
  • C. Stein, Inadmissibility of the usual estimator for the mean of a multivariate normal distribution, Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability, 1956, pp. 197–206.
  • M.C.K. Tweedie, Functions of a statistical variate with given means, with special reference to Laplacian distributions, Proc. Camb. Philos. Soc. 13 (1947), pp. 41–49. doi: 10.1017/S0305004100023185
  • H.C. van Houwelingen, The role of empirical Bayes methodology as a leading principle in modern medical statistics, Biom. J. 56 (2014), pp. 919–932. doi: 10.1002/bimj.201400073
  • R. Varadhan and S. -J. Wang, Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else, Biom. J. 58 (2016), pp. 133–153. doi: 10.1002/bimj.201400102
  • J.D. Wallach, P.G. Sullivan, J.F. Trepanowski, K.L. Sainani, E.W. Steyerberg, and J.P.A. Ioannidis, Evaluation of evidence os statistical support and corroboration of subgroup claims in randomized clinical trials, JAMA. Intern. Med. 177 (2017), pp. 554–560.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.